img
img
Cardioprotective effects of carvacrol in the isoproterenol-induced myocardial infarction model      
Yazarlar (4)
Dr. Öğr. Üyesi Seda KOÇAK Dr. Öğr. Üyesi Seda KOÇAK
Türkiye
Dr. Öğr. Üyesi Kübra Tuğçe KALKAN Dr. Öğr. Üyesi Kübra Tuğçe KALKAN
Kırşehir Ahi Evran Üniversitesi, Türkiye
Ömürcan Sadettin Aydın
Dr. Öğr. Üyesi Kübra ÖZTÜRK Dr. Öğr. Üyesi Kübra ÖZTÜRK
Türkiye
Devamını Göster
Özet
Objective: Cardiovascular diseases are significant health problems that cause high mortality rates worldwide. Myocardial infarction (MI), in particular, is one of the leading conditions among these diseases. The aim of this study is to evaluate the potential therapeutic approach of carvacrol in the treatment of cardiovascular diseases by investigating its protective effects against myocardial infarction through oxidative stress and biomarker levels. Materials and methods: In this study, 28 male Wistar albino rats were used, and divided into 4 groups: Control, Carvacrol, Myocardial Infarction (MI), and MI + Carvacrol. Carvacrol was administered at a dose of 50 mg/kg for six weeks. The induction of MI was performed during the last 2 days of carvacrol administration by administering 100 mg/kg isoproterenol subcutaneously. At the end of the experiment, blood pressure, biomarkers such as troponin T, BNP, GDF-15, and IL-6 were measured, and cardiac tissue was histopathologically examined. Results: The results show that in the MI group, troponin T, BNP, IL-6 and GDF-15 levels were increased, while diastolic blood pressure and heart rate were decreased. In the carvacrol-treated group, troponin T, BNP, IL-6 and GDF-15 levels were decreased. Carvacrol did not significantly affect systolic, diastolic, mean arterial pressure, or heart rate in experimental groups. Moreover, carvacrol decreased necrosis, edema, and mononuclear cell infiltration in the heart tissue, which were increased due to MI. Conclusion: In conclusion, carvacrol demonstrated protective effects against myocardial infarction. Carvacrol alleviated histopathological damage by reducing inflammatory biomarkers. In addition to carvacrol improved troponin T and BNP markers.These findings suggest that carvacrol may be a promising agent in the treatment of cardiovascular diseases. However, more comprehensive and long-term studies are needed to confirm this effect and transfer it to clinical applications.
Anahtar Kelimeler
BNP | carvacrol | GDF-15 | IL-6 | Myocardial infarction | Troponin T
Makale Türü Özgün Makale
Makale Alt Türü SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale
Dergi Adı BMC Pharmacology and Toxicology
Dergi ISSN 2050-6511 Wos Dergi Scopus Dergi
Dergi Tarandığı Indeksler SCI-Expanded
Dergi Grubu Q2
Makale Dili İngilizce
Basım Tarihi 07-2025
Cilt No 26
Sayı 132
Sayfalar 1 / 12
Doi Numarası 10.1186/s40360-025-00967-3
Makale Linki https://doi.org/10.1186/s40360-025-00967-3
BM Sürdürülebilir Kalkınma Amaçları
Atıf Sayıları
Cardioprotective effects of carvacrol in the isoproterenol-induced myocardial infarction model

Paylaş